Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    UI and metadata updates are minor: a glossary toggle is now shown, the Last Update Submitted that Met QC Criteria label is displayed, a No FEAR Act Data link is included, and the site revision is updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:11:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Minor revision from v3.3.3 to v3.3.4 with no detectable changes to study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:58.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a top-level Locations section listing Illinois, Maryland, and Texas, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T20:19:23.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.2.0 updated to v3.3.2; no substantive changes to study content or layout detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:37:15.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The government operating-status notice has been removed; study details, eligibility requirements, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:41.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.